Rising Prevalence Of Chronic Kidney Disease Driving The Growth Of The Market Due To Increasing Diabetes Rates And Kidney Function Impairment: The Driving Engine Behind Iron Deficiency Anemia Treatment Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Iron Deficiency Anemia Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size for treating iron deficiency anemia has seen swift development in the recent past. The market expansion is expected to surge from $7.85 billion in 2024 to $8.83 billion in 2025, with a compound annual growth rate (CAGR) of 12.5%. Factors that have contributed to this growth in the historic period include an increased number and reach of awareness programs and schemes, an aging baby-boomer demographic, an increase in nutritional deficiencies, a rise in global anemia cases, and a spike in the number of women in their childbearing years.

How Will the Iron Deficiency Anemia Treatment Market Size Evolve and Grow by 2029?
In the coming years, the market for treating iron deficiency anemia is set to experience significant expansion. The projected growth is to reach $14.36 billion in 2029 with a 12.9% compound annual growth rate (CAGR). This expected growth within the prediction period is due to an escalation in research and development funding, an increased risk in pregnancy, a rise in nutritional shortfalls, enhanced healthcare awareness, and the widespread occurrence of iron deficiency anemia. Key trends expected during this prediction period encompass the use of wearable devices for monitoring hemoglobin, patient-oriented chatbots, iron absorption boosters, remote monitoring platforms, and neurocognitive monitoring tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-treatment-global-market-report

What Drivers Are Propelling the Growth of Iron Deficiency Anemia Treatment Market Forward?
The anticipated rise in chronic kidney disease (CKD) is predicted to boost the expansion of the iron deficiency anemia treatment market. Chronic kidney disease epitomizes the slow degeneration of kidney functions over a period. The escalating rates of diabetes could account for the surge in chronic kidney disease, as elevated blood sugar levels over a long period damage the blood vessels in the kidneys and impede their waste filtration abilities. Iron deficiency anemia treatment assists chronic kidney disease by enhancing the oxygen supply to tissues, decreasing tiredness, improving the quality of life, and could potentially boost kidney function by addressing the consequent anemia from reduced production of erythropoietin in chronic kidney disease. As an example, a report by the UK-based pharmaceutical company AstraZeneca in April 2024, forecasted that by 2032, about 16.5% of the population in eight countries including the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia will suffer from chronic kidney disease, with an impressive soar up to 59.3% in acute-stage cases. Consequently, the rise in chronic kidney disease contributes to the burgeoning growth of the iron deficiency anemia treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24266&type=smp

Which Emerging Trends Are Transforming the Iron Deficiency Anemia Treatment Market in 2025?
Leading firms in the iron deficiency anemia treatment market are striving to create next-generation interventions, like iron injections, to improve treatment effectiveness, safety, and patient comfort. Iron injection is a breakthrough injectable iron therapy that is either new or substantially improved, providing a major advancement in treating iron deficiency or iron deficiency anemia. For example, in March 2024, Cadila Pharmaceuticals, a pharmaceutical company from India, introduced Redshot FCM. This is an intravenous iron therapy utilizing ferric carboxymaltose for managing iron deficiency anemia (IDA). It comes with unique attributes such as an advanced ferric carboxymaltose formulation for quick iron restoration, low risk of anaphylaxis, high-dose single-infusion administration for prompt correction, and suitability for both adults and children over one-year-old. This therapy speeds up hemoglobin recovery and focuses on high-risk populations, including expectant mothers and cancer patients, and is well-tolerated.

What Are the Key Segments in the Iron Deficiency Anemia Treatment Market?
The iron deficiency anemia treatment market covered in this report is segmented -

1) By Treatment Type: Medications, Blood Transfusions, Other Treatment Types
2) By Drug Type: Ferrous Sulfate, Iron Carbohydrates, Other Drug Types
3) By Therapy Areas: Inflammatory Bowel Disease, Oncology, Other Therapy Areas
4) By Route Of Administration: Oral, Injectable
5) By End User: Hospitals, Clinics, Home Care Settings, Pharmacies

Subsegments:
1) By Medications: Oral Iron Supplements, Intravenous Iron Therapy, Iron-Based Injections, Erythropoiesis-Stimulating Agents
2) By Blood Transfusions: Packed Red Blood Cells Transfusion, Whole Blood Transfusion
3) By Other Treatment Types: Dietary Modifications, Iron Infusion Therapy, Bone Marrow Stimulation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24266&type=smp

Who Are the Key Players Shaping the Iron Deficiency Anemia Treatment Market's Competitive Landscape?
Major companies operating in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories, Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Akebia Therapeutics Inc., Pharmacosmos A/S, Pieris Pharmaceuticals Inc., AdvaCare Pharma USA LLC, Apotex Inc., Shield Therapeutics plc.

What Geographic Markets Are Powering Growth in the Iron Deficiency Anemia Treatment Market?
North America was the largest region in the iron deficiency anemia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24266

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.